Access the science, technology and contacts that you need to accelerate your biologics and novel products towards commercial success.

Formulation development of microbiome therapeutics localized in the intestines

Share this article

Microbiome drugs are delivered to specific locations within the gastrointestinal tract, so they must be formulated for targeted release without systemic absorption. With few examples on the market, formulation is a growing concern for developers of these medicines.

In this article from BioProcess International, the authors from Synthetic Biologics describe the rationale, design, and evaluation of microbiome products, while discussing challenges and possible solutions for localized intestinal delivery.

Read the full article here...

Share this article

Upcoming event

BioProcess International Europe

28 Apr - 01 May 2020, Amsterdam
Europe’s Leading BioProcessing Event for Accelerating Biologics, mAbs, Vaccines and Novel Products to Commercial Success
Go to site